You are here

  • Home
  • Archive
  • Volume 81, Issue 10
  • Education and treatment adherence during the COVID-19 pandemic. Response to: ‘Adherence to medication in patients with rheumatic diseases during COVID-19 pandemic’ by Khabbazi et al

Article Text

Article menu
Download PDFPDF
Correspondence response
Education and treatment adherence during the COVID-19 pandemic. Response to: ‘Adherence to medication in patients with rheumatic diseases during COVID-19 pandemic’ by Khabbazi et al
  1. Rita Angélica Pineda-Sic1,
  2. Griselda Serna-Peña1,
  3. Jesus Alberto Cardenas-de la Garza1,
  4. Sergio A Torres-Castillo2,
  5. Dionicio Angel Galarza-Delgado1,
  6. Diana Elsa Flores-Alvarado1
  1. 1 Rheumatology, Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo Leon, Mexico
  2. 2 Servicio de Neurología, Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo Leon, Mexico
  1. Correspondence to Dr Dionicio Angel Galarza-Delgado, Rheumatology, Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo Leon, PC 64460, Mexico; dgalarza{at}medicinauanl.mx

https://doi.org/10.1136/annrheumdis-2020-218791

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    With great interest, we read the study of Dr Khabbazi et al 1 regarding treatment adherence in patients with inflammatory rheumatic diseases during the COVID-19 pandemic in the East Azarbaijan province of Iran. They conducted telephone interviews to 1324 patients and inquired about treatment adherence behaviours during 2 weeks from July 2020. Of the 858 patients included in the final analysis, non-adherence was reported by 6.5% of the patients (defined by the group as ≥20% change in the dose or frequency of medications). In accordance to previous studies, …

    View Full Text

    Footnotes

    • Handling editor Josef S Smolen

    • Twitter @ritapineda_6, @DraGrisSerna, @sactMD

    • Contributors RAP-S and GS-P, conceived the manuscript. RAP-S, GS-P, JAC-dlG, SAT-C, DAG-D and DEF-A drafted and revised the manuscript for important intellectual content.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient and public involvement Patients and/or the public were not involved in the design, conduct, reporting or dissemination plans of this research.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles